FindMyRecallSubscribe
Class I: serious health riskTerminated

Westminster Pharmaceuticals Levothyroxine and Liothyronine Recall

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/4 grain (15 mg), 100-count bot…

Westminster Pharmaceuticals LLC · Olive Branch, MS

Risk level
Class I
Reported by FDA
Aug 29, 2018
Recall ID
D-1181-2018
Check your lot numberHow we source this data

Summary

Westminster Pharmaceuticals recalled Levothyroxine and Liothyronine starting Aug 3, 2018. The FDA classified it as Class I (serious health risk) and published enforcement report D-1181-2018 on Aug 29, 2018. Reason: Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled. Status: Terminated.

Why it was recalled

Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.

Product description

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/4 grain (15 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-159-04.

Lot numbers, UPCs & expiration codes

Lot #: 15917VP03, 15917VP02, 15917VP01, Exp 10/31/2019; 15918004, 15918003, 15918002, 15918001, Exp 12/31/2019; 15918VP03, 15918VP02, 15918VP01, 15918005, Exp 2/29/2020; 15918007, 15918006, Exp 3/31/2020.

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1181-2018
Classification
Class I
Status
Terminated
Recall initiated
Aug 3, 2018
FDA report date
Aug 29, 2018
Quantity
Unknown
Recall type
Voluntary: Firm initiated
Recalling firm
Westminster Pharmaceuticals LLC

Original FDA data

Every field from FDA enforcement report D-1181-2018, exactly as published.

Show all FDA fields
City
Olive Branch
State
MS
Status
Terminated
Country
United States
Event ID
80719
Address
1 & 2
Address (line 2)
154 Downing Street
Code information
Lot #: 15917VP03, 15917VP02, 15917VP01, Exp 10/31/2019; 15918004, 15918003, 15918002, 15918001, Exp 12/31/2019; 15918VP03, 15918VP02, 15918VP01, 15918005, Exp 2/29/2020; 15918007, 15918006, Exp 3/31/2020.
Postal code
38654
Report date
Aug 29, 2018
Product type
Drugs
Recall number
D-1181-2018
Classification
Class I
Recalling firm
Westminster Pharmaceuticals LLC
Product quantity
Unknown
Termination date
Jun 3, 2020
Reason for recall
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/4 grain (15 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-159-04.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Aug 3, 2018
Initial firm notification
Letter
Center classification date
Sep 7, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1181-2018, published Aug 29, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls